Strategies to Slow the Onset of Blindness in Retinitis Pigmentosa
Air date: Wednesday, September 29, 2010, 3:00:00 PM
Time displayed is Eastern Time, Washington DC Local
Category: Wednesday Afternoon Lectures
Description: The disease, retinitis pigmentosa (RP), is a blinding illness with genetic etiology. Many different RP genes are expressed in rod photoreceptors exclusively. These are the retinal photoreceptors used for dim light perception, or night vision. Individuals born with these mutations have poor, or no, night vision, but typically have normal daylight and color vision. The rods often deteriorate and die, leading to a complete loss of night vision. Subsequently, the cones, which mediate daylight and color vision, also die, over a period of years, leading to a complete loss of all vision.
We are interested in learning how to stop the progression of RP. To this end, we have investigated the causes of cone death using microarrays and 4 mouse models of RP, looking for changes that are in common across all 4 models at the onset of cone death. Genes that are involved in metabolism were those with the most frequently observed changes. These observations were followed up through several independent assays. The results suggest that cones are starving, potentially leading to their malfunction and death. In addition, we examined the activity of histone deacetylase 4 (HDAC4) in promoting rod survival. When overexpressed in rods, HDAC4 significantly prolonged rod survival, and indirectly, cone survival. This activity required the activity of hypoxia inducible factor 1alpha.
The NIH Director's Wednesday Afternoon Lecture Series includes weekly scientific talks by some of the top researchers in the biomedical sciences worldwide.
Author: Dr. Connie Cepko
Runtime: 01:01:49
Permanent link: http://videocast.nih.gov/launch.asp?16149
Видео Strategies to Slow the Onset of Blindness in Retinitis Pigmentosa канала NIH VideoCast
Time displayed is Eastern Time, Washington DC Local
Category: Wednesday Afternoon Lectures
Description: The disease, retinitis pigmentosa (RP), is a blinding illness with genetic etiology. Many different RP genes are expressed in rod photoreceptors exclusively. These are the retinal photoreceptors used for dim light perception, or night vision. Individuals born with these mutations have poor, or no, night vision, but typically have normal daylight and color vision. The rods often deteriorate and die, leading to a complete loss of night vision. Subsequently, the cones, which mediate daylight and color vision, also die, over a period of years, leading to a complete loss of all vision.
We are interested in learning how to stop the progression of RP. To this end, we have investigated the causes of cone death using microarrays and 4 mouse models of RP, looking for changes that are in common across all 4 models at the onset of cone death. Genes that are involved in metabolism were those with the most frequently observed changes. These observations were followed up through several independent assays. The results suggest that cones are starving, potentially leading to their malfunction and death. In addition, we examined the activity of histone deacetylase 4 (HDAC4) in promoting rod survival. When overexpressed in rods, HDAC4 significantly prolonged rod survival, and indirectly, cone survival. This activity required the activity of hypoxia inducible factor 1alpha.
The NIH Director's Wednesday Afternoon Lecture Series includes weekly scientific talks by some of the top researchers in the biomedical sciences worldwide.
Author: Dr. Connie Cepko
Runtime: 01:01:49
Permanent link: http://videocast.nih.gov/launch.asp?16149
Видео Strategies to Slow the Onset of Blindness in Retinitis Pigmentosa канала NIH VideoCast
Показать
Комментарии отсутствуют
Информация о видео
Другие видео канала
![A Stem Cell-Based Therapy for Retinitis Pigmentosa](https://i.ytimg.com/vi/22MC8O-i0K4/default.jpg)
![Jamie has Retinitis Pigmentosa and lost her vision. A bionic eye has her smiling again.](https://i.ytimg.com/vi/W5NoK9A91pg/default.jpg)
![Neurology - Nerve Damage and Regeneration](https://i.ytimg.com/vi/OKr-9WJTHME/default.jpg)
![What losing my vision taught me about access | Luis Perez](https://i.ytimg.com/vi/XVynmCOeLoM/default.jpg)
![Can we defeat the diseases of aging? | James Peyer | TEDxStuttgart](https://i.ytimg.com/vi/tFRMenhklYE/default.jpg)
![Gene Therapy for Retinal Disease](https://i.ytimg.com/vi/JAIdAYNZ44k/default.jpg)
![Retinitis Pigmentosa | Genetics, Pathophysiology, Signs & Symptoms, Diagnosis, Treatment](https://i.ytimg.com/vi/o0__ZphE3mM/default.jpg)
![Imaging Immunity](https://i.ytimg.com/vi/c-zgohBPx-0/default.jpg)
![Rosie's Story: Treating Retinitis Pigmentosa](https://i.ytimg.com/vi/BjcnCD4kkBo/default.jpg)
![Decoding the human genome: getting to 20/20](https://i.ytimg.com/vi/dJR3jlw_JwY/default.jpg)
![Retinitis Pigmentosa (RP) can be cured by the Palm Pressure Therapy (or Eye Massage)](https://i.ytimg.com/vi/uZkBmgeCAFY/default.jpg)
![Clinical trials design and study endpoints](https://i.ytimg.com/vi/1jnYpJYZK-c/default.jpg)
![Ancient DNA and the new science of the human past](https://i.ytimg.com/vi/EfHGhWfxWoA/default.jpg)
![ProQR Usher Syndrome Type 2 Development Program, Hester van Diepen, PhD](https://i.ytimg.com/vi/oBa7K5ZWKOA/default.jpg)
![Usher Syndrome Resources and Update](https://i.ytimg.com/vi/js5AkKaVkzg/default.jpg)
![Part 2: Cortical/Cerebral Visual Impairment - What is it? with Darick Wright and Barry Kran](https://i.ytimg.com/vi/t4exCMip0_Y/default.jpg)
![IPPCR - Disasters and Other Humanitarian Crises Part 2 of 4](https://i.ytimg.com/vi/e6zsUIZYBxM/default.jpg)
![Immuno Oncology 2021 and Beyond](https://i.ytimg.com/vi/QAG2K4-X0vI/default.jpg)
![IPPCR - Health Disparities Research: Better Health Outcomes for All Part 3 of 4](https://i.ytimg.com/vi/Ifu97WIoGX8/default.jpg)
![A Scientist Explains My Eye Disease! ft. It’s Okay To Be Smart](https://i.ytimg.com/vi/MOmRQb7h5lw/default.jpg)